[Principles of immunoregulation in autoimmune syndromes].
D000276:Adjuvants, Immunologic; D000328:Adult; D000368:Aged; D000818:Animals; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000209:etiology*; D001327:Autoimmune Diseases / Q000188:drug therapy / Q000209:etiology*; D002648:Child; D006521:Hepatitis, Chronic / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D007223:Infant; D007978:Levamisole / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000209:etiology*; D008231:Lymphopenia / Q000150:complications / Q000188:drug therapy; D051379:Mice; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000209:etiology*; D050378:T-Lymphocytes, Regulatory / Q000276:immunology; D013947:Thymosin / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D007978:Levamisole; D013947:Thymosin
Podstawy immunoregulacji w zespołach autoimmunoagresyjnych.